These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7557191)

  • 41. Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer.
    Keeley SB; Pennathur A; Gooding W; Landreneau RJ; Christie NA; Luketich J
    Ann Surg Oncol; 2007 Aug; 14(8):2406-10. PubMed ID: 17534685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management strategies for Barrett's esophagus.
    Hillman L
    J Gastroenterol Hepatol; 2007 Jun; 22(6):771-2. PubMed ID: 17565627
    [No Abstract]   [Full Text] [Related]  

  • 43. Barrett's esophagus: results of a multicentric survey. G.O.S.P.E. (Gruppo Operativo per lo Studio delle Precancerosi Esofagee.
    Bonelli L
    Endoscopy; 1993 Nov; 25(9):652-4. PubMed ID: 8119225
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
    Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mechanism of photodynamic therapy].
    Takemura T; Nakajima S; Sakata I
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):16-21. PubMed ID: 8546463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
    O'Connor JB; Falk GW; Richter JE
    Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
    Thrift AP
    Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus.
    Buttar NS; Wang KK; Lutzke LS; Krishnadath KK; Anderson MA
    Gastrointest Endosc; 2001 Dec; 54(6):682-8. PubMed ID: 11726842
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Epidemiology of Barrett's esophagus--comparison of Japan and the West].
    Hanai M; Kusano M; Kawamura O; Shimoyama Y; Maeda M
    Nihon Rinsho; 2005 Aug; 63(8):1333-9. PubMed ID: 16101218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus.
    Kastelein F; Spaander MC; Biermann K; Steyerberg EW; Kuipers EJ; Bruno MJ;
    Gastroenterology; 2011 Dec; 141(6):2000-8; quiz e13-4. PubMed ID: 21878200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west.
    Jankowski JA; Provenzale D; Moayyedi P
    Gastroenterology; 2002 Feb; 122(2):588-90. PubMed ID: 11845805
    [No Abstract]   [Full Text] [Related]  

  • 53. [Eradication of high-grade dysplasia in Barrett esophagus by photodynamic therapy with endogenously generated protoporphyrin IX].
    Ortner M; Lochs H
    Z Gastroenterol; 1998 Jan; 36(1):111-3. PubMed ID: 9531692
    [No Abstract]   [Full Text] [Related]  

  • 54. Photodynamic therapy for Barrett's esophagus: not yet ready for the premier league of endoscopic interventions.
    Siersema PD
    Gastrointest Endosc; 2005 Oct; 62(4):503-7. PubMed ID: 16185961
    [No Abstract]   [Full Text] [Related]  

  • 55. Multilayered epithelium may be found in patients with Barrett's epithelium and dysplasia or adenocarcinoma.
    Upton MP; Nishioka NS; Ransil BJ; Rosenberg SJ; Puricelli WP; Zwas FR; Shields HM
    Dig Dis Sci; 2006 Oct; 51(10):1783-90. PubMed ID: 16967312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation.
    Cen P; Correa AM; Lee JH; Maru D; Anandasabapathy S; Liao Z; Hofstetter WL; Swisher SG; Komaki R; Ross WA; Vaporciyan A; Ajani JA
    Dis Esophagus; 2009; 22(1):32-41. PubMed ID: 19021684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advances in Barrett's esophagus and esophageal adenocarcinoma.
    Shaheen NJ
    Gastroenterology; 2005 May; 128(6):1554-66. PubMed ID: 15887151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Results of photodynamic therapy in Barrett's esophagus: A review.
    Overholt BF
    Can J Gastroenterol; 1999 Jun; 13(5):393-6. PubMed ID: 10377469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The incidence of esophageal adenocarcinoma in Barrett's esophagus has been overestimated.
    Desai TK; Singh J; Samala N; Subbiah P
    Am J Gastroenterol; 2011 Jul; 106(7):1364-5; author reply 1365-6. PubMed ID: 21731021
    [No Abstract]   [Full Text] [Related]  

  • 60. The incidence of esophageal adenocarcinoma among patients with nondysplastic Barrett's esophagus has been overestimated.
    Desai TK; Samala N
    Clin Gastroenterol Hepatol; 2011 Apr; 9(4):363-4; author reply 364-5. PubMed ID: 21115135
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.